Pre-Diligence Memos

We're not telling investors what to think — we're helping you see the terrain faster.

Early-stage risk is real, but its interpretation is inherently subjective. Two thoughtful investors can review the same company and reach different conclusions. The Assumption & Evidence Briefs, produced by our Pre-Diligence Lab, support faster, more intentional deal triage — without replacing your judgment.

How It Works

The Lab produces 3–5 page Assumption & Evidence Briefs, structured as risk maps to surface and organize areas of uncertainty investors uncover over time. Synthesized from pitch decks, founder Q&A, and light research, each brief is a decision-support starting point — perfect for time-constrained or newer investors.

When Is This Most Useful?

The Brief is most valuable pre-meeting or between first exposure and deeper dives — helping investors decide how much time and attention to allocate.

Use the Briefs to Quickly Decide:

• Whether to take an introductory meeting
• Whether to invite a founder to pitch
• How to moderate group discussion toward consensus
• Where to focus initial questions to the founder

Who Is This Best Suited For?

• Angel groups and syndicates
• Newer investors building judgment
• Experienced investors managing high deal volume
• Programs training future investors

This is about decision orientation without decision automation — useful both for self-reflection and group decision-making.

Give our investor framework a try here: Risk Topography

Why Join

As an angel participant, you gain clearer early-stage signals while helping build durable judgment capacity across the ecosystem. The Lab respects your time, sharpens your decision process, and compounds impact beyond any single deal.